Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder
about
Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.Psychosexual disorders and dermatologistsPharmacology of serotonin and female sexual behaviorThe Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.The pharmacodynamic effects of combined administration of flibanserin and alcohol.Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.Flibanserin: Approval of a controversial drug for a controversial disorderMotivated behaviors and levels of 3α,5α-THP in the midbrain are attenuated by knocking down expression of pregnane xenobiotic receptor in the midbrain ventral tegmental area of proestrous rats.Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.Managing low sexual desire in women.Testosterone supplementation for hypoactive sexual desire disorder in women.Pharmacogenomics and sexuality: a vision.Flibanserin - the female Viagra?Animal Models for the Study of Female Sexual Dysfunction.New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.Female sexual dysfunction: a focus on flibanserin.Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.Next-day residual effects of flibanserin on simulated driving performance in premenopausal women.Brain neuronal activation induced by flibanserin treatment in female rats.Flibanserin-Stimulated Partner Grooming Reflects Brain Metabolism Changes in Female Marmosets.Flibanserin toxicity in a toddler following ingestion.Evaluation and Management of Hypoactive Sexual Desire Disorder.
P2860
Q22242315-F43C5DC4-EE1B-4844-B1BD-BD44A85C7B28Q26746754-13CC9BA1-93F3-4474-A56E-9C33ADD07210Q26861672-20A941ED-57EB-416E-A8E3-698F16AB878BQ30278438-4EA58371-C0C0-42C2-8DAB-55E52BE7AB85Q33166265-C78C3C91-4313-447F-888B-A78E9826EAB0Q33168748-C7E21E86-A0BE-4898-AA72-3A025BDF3478Q33687521-D639786B-037B-49AD-96E6-2A991E64D428Q34043125-94B3A69A-C525-4E00-8259-F95C02383422Q34336933-A7879B02-9864-4518-BAF0-F9AB5CAD6965Q35538516-7EE0C493-C006-469D-8952-D9B974D68EBEQ36216746-A48B2F79-8666-4FC2-9343-A7FBE32DBE98Q36979907-150E2C24-C799-428B-B769-2CBBD6CA2167Q37711908-7D62ADE5-7256-48F9-A7E0-726E480A4BCFQ37924289-DAC74718-6B41-4929-94AF-3A85AD7B17F0Q37990887-3433F329-95C9-44AD-8314-7E237386B54FQ38121154-E72377C2-78F9-49BE-91E2-285C284D5884Q38824509-2F615F25-5590-4BAE-82A5-3F41C34A89ECQ38991824-4B37F3A5-B01F-4D9F-8BBB-F23E441BAF14Q39262633-2B6F602F-5472-47C0-B292-D0DE4C9B6643Q42647545-01C710AD-BB47-4AD7-8CED-329A06E50835Q42688204-4400D71E-5273-48F5-A6D2-5D38F82F5FF1Q45065520-4E13DB9B-E5D7-41DC-8D8B-D223B4C99A8BQ46204748-EEC1E1AE-2811-4841-8C49-D4612976222FQ47868863-892009FA-4AD5-45A8-90C4-07350D24A579Q48094293-0E80F579-0D46-4027-8A76-B9248B2A2587Q50502199-08BB572A-5BFC-4C84-9F3D-D05A0B844DC5Q53437731-63F0E2FB-ABC9-4D95-8E74-2A0776335890
P2860
Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Multifunctional pharmacology o ...... oactive sexual desire disorder
@ast
Multifunctional pharmacology o ...... oactive sexual desire disorder
@en
Multifunctional pharmacology o ...... oactive sexual desire disorder
@nl
type
label
Multifunctional pharmacology o ...... oactive sexual desire disorder
@ast
Multifunctional pharmacology o ...... oactive sexual desire disorder
@en
Multifunctional pharmacology o ...... oactive sexual desire disorder
@nl
prefLabel
Multifunctional pharmacology o ...... oactive sexual desire disorder
@ast
Multifunctional pharmacology o ...... oactive sexual desire disorder
@en
Multifunctional pharmacology o ...... oactive sexual desire disorder
@nl
P2093
P3181
P1476
Multifunctional pharmacology o ...... oactive sexual desire disorder
@en
P2093
Bernd Sommer
Kelly A Allers
Stephen M Stahl
P3181
P356
10.1111/J.1743-6109.2010.02032.X
P407
P577
2011-01-01T00:00:00Z